| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2014 ( Subtotal = $0 ) |
| | 2014 | 2013 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R43AR064067 | Oral delivered bone building therapy for osteoporosis | 000 | 1 | NIH | 2/27/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $475,076 ) |
| | 2013 | 2013 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R43AR064067 | Oral delivered bone building therapy for osteoporosis | 000 | 1 | NIH | 5/8/2013 | $475,076 |
| | 2013 | 2013 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R43AR064067 | Oral delivered bone building therapy for osteoporosis | 001 | 1 | NIH | 2/27/2014 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $556,396 ) |
| | 2009 | 2009 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R44AR052962 | ANABOLIC THERAPEUTICS FOR INCREASING BONE DENISTY AND QUALITY | 001 | 3 | NIH | 7/29/2009 | $556,396 |
| | 2009 | 2008 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R44AR052962 | ANABOLIC THERAPEUTICS FOR INCREASING BONE DENISTY AND QUALITY | 000 | 2 | NIH | 7/29/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $460,587 ) |
| | 2008 | 2008 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R44AR052962 | ANABOLIC THERAPEUTICS FOR INCREASING BONE DENISTY AND QUALITY | 000 | 2 | NIH | 8/28/2008 | $460,587 |
|
| Issue Date FY: 2006 ( Subtotal = $133,904 ) |
| | 2006 | 2006 | OSTEOGENEX INC | 4407 NORTHEAST 80 TERRACE | KANSAS CITY | MO | 64119 | CLAY | USA | R43AR052962 | THERAPEUTICS FOR INCREASING BONE DENSITY AND QUALITY | 000 | 1 | NIH | 6/2/2006 | $133,904 |
|
|
